Cargando…

A New Fusion Peptide Targeting Pancreatic Cancer and Inhibiting Tumor Growth

BACKGROUND: Pancreatic cancer is a highly malignant tumor of the digestive system. Early pancreatic cancer is often difficult to diagnosis due to its atypical clinical symptoms. Patients with pancreatic cancer have a very poor prognosis because they have lost the opportunity for radical surgical tum...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zheng, Lei, Zhang, Bo, He, Xiaoman, Cao, Guodong, Li, Yongzhou, Cai, Kailun, Yang, Bin, Wu, Yulian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434629/ https://www.ncbi.nlm.nih.gov/pubmed/32884283 http://dx.doi.org/10.2147/OTT.S246969

Ejemplares similares

FHL3 promotes pancreatic cancer invasion and metastasis through preventing the ubiquitination degradation of EMT associated transcription factors
por: Li, Pengping, et al.
Publicado: (2020)

O-GlcNAcylation and stablization of SIRT7 promote pancreatic cancer progression by blocking the SIRT7-REGγ interaction
por: He, Xiaoman, et al.
Publicado: (2022)

Exosomes Derived from Pancreatic Cancer Cells Induce Osteoclast Differentiation Through the miR125a-5p/TNFRSF1B Pathway
por: Zhou, Yizhao, et al.
Publicado: (2021)

VEGF-Modified PVA/Silicone Nanofibers Enhance Islet Function Transplanted in Subcutaneous Site Followed by Device-Less Procedure
por: Yang, Bin, et al.
Publicado: (2020)

CHIP is a novel tumor suppressor in pancreatic cancer and inhibits tumor growth through targeting EGFR
por: Wang, Tianxiao, et al.
Publicado: (2014)

Honeysuckle-derived microRNA2911 inhibits tumor growth by targeting TGF-β1
por: Liu, Chunyan, et al.
Publicado: (2021)

Identification and Validation of a New Peptide Targeting Pancreatic Beta Cells
por: Wang, Qianwen, et al.
Publicado: (2022)

Monensin inhibits cell proliferation and tumor growth of chemo-resistant pancreatic cancer cells by targeting the EGFR signaling pathway
por: Wang, Xin, et al.
Publicado: (2018)

Copper oxide nanoparticles inhibit pancreatic tumor growth primarily by targeting tumor initiating cells
por: Benguigui, Madeleine, et al.
Publicado: (2019)

Targeted IFNγ induction by a genetically engineered Salmonella typhimurium is the key to the liver metastasis inhibition in a mouse model of pancreatic neuroendocrine tumor
por: Hua, Zhan, et al.
Publicado: (2023)

Inhibition of Viral Membrane Fusion by Peptides and Approaches to Peptide Design
por: Düzgüneş, Nejat, et al.
Publicado: (2021)

The human cathelicidin peptide LL-37 inhibits pancreatic cancer growth by suppressing autophagy and reprogramming of the tumor immune microenvironment
por: Zhang, Zhu, et al.
Publicado: (2022)

Genetically engineered endostatin-lidamycin fusion proteins effectively inhibit tumor growth and metastasis
por: Jiang, Wen-guo, et al.
Publicado: (2013)

Targeting Endoglin Expressing Cells in the Tumor Microenvironment Does Not Inhibit Tumor Growth in a Pancreatic Cancer Mouse Model
por: Schoonderwoerd, Mark J A, et al.
Publicado: (2021)

Phenylethynylbenzyl-modified biguanides inhibit pancreatic cancer tumor growth
por: Hébert, Audrey, et al.
Publicado: (2021)

Fusion of cell-penetrating peptides to thermally responsive biopolymer improves tumor accumulation of p21 peptide in a mouse model of pancreatic cancer
por: Walker, Leslie R, et al.
Publicado: (2014)

A targeted transforming growth factor-beta (TGF-β) blocker, TTB, inhibits tumor growth and metastasis
por: Zhou, Changhua, et al.
Publicado: (2018)

Inhibition of Henipavirus fusion and infection by heptad-derived peptides of the Nipah virus fusion glycoprotein
por: Bossart, Katharine N, et al.
Publicado: (2005)

BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth
por: Boreddy, Srinivas Reddy, et al.
Publicado: (2023)

Molecular targeting of cell-permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferation
por: Sato, Shoki, et al.
Publicado: (2017)

Broadly neutralizing antibodies target the coronavirus fusion peptide
por: Dacon, Cherrelle, et al.
Publicado: (2022)

Broadly neutralizing antibodies target the coronavirus fusion peptide
por: Dacon, Cherrelle, et al.
Publicado: (2022)

Targeting hypoxic tumor microenvironment in pancreatic cancer
por: Tao, Jinxin, et al.
Publicado: (2021)

Inhibition of PlexA1-mediated brain tumor growth and tumor-associated angiogenesis using a transmembrane domain targeting peptide
por: Jacob, Laurent, et al.
Publicado: (2016)

Targeting Tumor Vascular CD99 Inhibits Tumor Growth
por: Huijbers, Elisabeth J. M., et al.
Publicado: (2019)

Lipidation increases antiviral activities of coronavirus fusion-inhibiting peptides
por: Park, Jung-Eun, et al.
Publicado: (2017)

Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein
Publicado: (1992)

A Combination of Radiotherapy, Hyperthermia, and Immunotherapy Inhibits Pancreatic Tumor Growth and Prolongs the Survival of Mice
por: Mahmood, Javed, et al.
Publicado: (2020)

miR-532-3p Inhibits Proliferation and Promotes Apoptosis of Lymphoma Cells by Targeting β-Catenin
por: Liu, Yan, et al.
Publicado: (2020)

In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery
por: Tripodi, Andrea Angelo Pierluigi, et al.
Publicado: (2019)

Bis{1-[4-(benzyloxy)phenyl]-4,4,4-trifluorobutane-1,3-dionato(1−)}dipyridinecobalt(II)
por: Fan, Ling, et al.
Publicado: (2011)

Inhibition of mTORC2 component RICTOR impairs tumor growth in pancreatic cancer models
por: Schmidt, Katharina M., et al.
Publicado: (2017)

CTEN Inhibits Tumor Angiogenesis and Growth by Targeting VEGFA Through Down-Regulation of β-Catenin in Breast Cancer
por: Lu, Xiangdong, et al.
Publicado: (2021)

Targeting Insulin-Like Growth Factor 1 Receptor Inhibits Pancreatic Cancer Growth and Metastasis
por: Subramani, Ramadevi, et al.
Publicado: (2014)

STM2457 Inhibits the Invasion and Metastasis of Pancreatic Cancer by Down-Regulating BRAF-Activated Noncoding RNA N6-Methyladenosine Modification
por: Hao, Shaolong, et al.
Publicado: (2023)

CDDO-Me inhibits tumor growth and prevents recurrence of pancreatic ductal adenocarcinoma
por: GAO, XIAOHUA, et al.
Publicado: (2015)

Tumor neoantigen heterogeneity impacts bystander immune inhibition of pancreatic cancer growth
por: Das, Manisit, et al.
Publicado: (2020)

Perturbation of Autophagy by a Beclin 1-Targeting Stapled Peptide Induces Mitochondria Stress and Inhibits Proliferation of Pancreatic Cancer Cells
por: Li, Na, et al.
Publicado: (2023)

Cholecystokinin Receptor-Targeted Polyplex Nanoparticle Inhibits Growth and Metastasis of Pancreatic Cancer
por: Burks, Julian, et al.
Publicado: (2018)

Targeting Growth Factor Signaling Pathways in Pancreatic Cancer: Towards Inhibiting Chemoresistance
por: Xelwa, Ntombikayise, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_08rps80pabgbo3ndbgvg4hmvh7